Title : Potentiating prostate cancer immunotherapy with oncolytic viruses.

Pub. Date : 2018 Apr

PMID : 29434366






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This oncolytic-virus-induced subversion of tumour-associated immunosuppression can potentiate the effectiveness of current immunotherapeutics, including immune checkpoint inhibitors (for example, antibodies against programmed cell death protein 1 (PD1), programmed cell death 1 ligand 1 (PDL1), and cytotoxic T lymphocyte antigen 4 (CTLA4)) and chemotherapeutics that induce immunogenic cell death (for example, doxorubicin and oxaliplatin). Doxorubicin programmed cell death 1 Sus scrofa